Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011
Rythmodan is used in the treatment of cardiac arrhythmias as follows:
Oral.
300 mg to 800mg daily in divided doses.
Not recommended as insufficient data available.
A dose reduction due to reduced renal and hepatic function in the elderly (especially elderly non-smokers) should be considered (see section 4.4)
There is no specific antidote for disopyramide. Prostigmine derivatives can be used to treat anticholinergic effects. Symptomatic supportive measures may include: early gastric lavage; administration of a cathartic followed by activated charcoal by mouth or stomach tube; IV administration of isoprenaline, other vasopressors and/or positive inotropic agents; if needed – infusion of lactate and/or magnesium, electro–systolic assistance, cardioversion, insertion of an intra–aortic balloon for counterpulsion and mechanically assisted ventilation. Haemodialysis, haemofiltration or haemoperfusion with activated charcoal has been employed to lower the serum concentrations of the drug.
PVC Blister: 36 months.
Do not store above 25°C.
Sanofi-aventis
One Onslow Street
Guildford
Surrey GU1 4YS
UK
PVC Blister containing 84 capsules.
None.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
